Aurigene Pharmaceutical Services Limited

🚀 We’re Live at the 7th TPD & Induced Proximity Summit! 🚀   Our experts are on the ground in Boston, ready to connect and share our latest advancements in targeted protein degradation. Don’t miss our poster presentation: "Design and Rapid Synthesis of RIPK-2 Degraders with Improved ADME and PK Parameters Using Our In-House Partial PROTAC Library."   📅 Dates: October 28-31, 2024 📍 Venue: Boston, MA   Want to discuss your projects or learn more about our cutting-edge research? Schedule a meeting with our team by writing to us at contactapsl@aurigeneservices.com.   Let’s accelerate your TPD journey together!   #TargetedProteinDegradation #TPDSummit #Aurigene #DrugDiscovery #ProteinDegradation #LiveEvent Prasad P W Appukkuttan Sreekar Reddy Sangamesh Badiger Gayathri Ramaswamy

🌟 Did You Know? 🌟 The Human Genome Project, completed in 2003, was a landmark achievement in genomics. It successfully mapped all the genes in the human genome, providing a comprehensive blueprint of human DNA. This monumental project has paved the way for advances in personalized medicine, allowing for treatments and therapies tailored to an individual’s genetic makeup, thereby improving efficacy and outcomes in healthcare. At Aurigene, we are committed to leveraging such groundbreaking discoveries to drive innovation and enhance our capabilities in drug development. Join us in celebrating the strides made in innovative healthcare that have made a profound impact on the life as we know it! #HumanGenomeProject #PersonalizedMedicine #HealthcareInnovation #Aurigene

🌍 Join Aurigene at Biomanufacturing World Summit 2024! 🌍   We're setting the pace at Biomanufacturing World Summit 2024!   📅 Booth No. - #02 | November 19-21, 2024 📍Hilton San Diego Bayfront | San Diego, CA   Join us in exploring new innovations and trends in biologics.   Aurigene’s experts, Dr. Roger Lias (Global Commercial Head - NBE) and Jenny Yip (Sr. Director, Business Development - Biologics, North America), are eager to meet you at Biomanufacturing World Summit 2024!   Discover our cutting-edge biologics and next-gen biotherapeutics advancements. Whether you're looking to streamline your development pipeline, explore collaboration opportunities, or dive into the latest innovations in commercial biologics, our specialists are ready to share insights and discuss how we can help accelerate your goals.   To schedule a meeting, write to us at contactapsl@aurigeneservices.com. #BiomanufacturingWorld #Biologics #BioTech #PharmaInnovation

🌍 Join Aurigene at Bio-Europe! 🌍   We're excited to announce that two of our CDMO experts, Roger Lias and ASHWINI KUMAR KAPOOR, will attend Bio-Europe 2024 to discuss how Aurigene’s small and large-molecule services can support and accelerate your molecule's journey from lab to market.    From discovery to commercial cGMP manufacturing, we deliver unmatched expertise across small and large molecules including niche modalities.   Looking to accelerate your molecule’s journey? Contact us at contactapsl@aurigeneservices.com to schedule a meeting with our experts at Bio-Europe. #BioEurope #Biologics #DrugDiscovery #DrugDevelopment

🌟 Exciting News! 🌟   Aurigene will be at the 7th TPD & Induced Proximity Summit in Boston from October 28-31, 2024. We’re thrilled to join this vibrant gathering of leaders advancing the field of targeted protein degradation (TPD). 🎯   🚀 Ready to accelerate your TPD journey? Two of our experts will be in attendance, showcasing our latest research with a poster titled: "Design and Rapid Synthesis of RIPK-2 Degraders with Improved ADME and PK Parameters Using Our In-House Partial PROTAC Library."   Write to us at contactapsl@aurigeneservices.com to explore innovative approaches, engage in valuable discussions, and advance your projects with insights from our team!   📍 Venue: Boston, MA 📅 Dates: October 28-31, 2024   #TargetedProteinDegradation #TPDSummit #Aurigene #DrugDiscovery #ProteinDegradation Sreekar Reddy Prasad P W Appukkuttan

Vaccination continues to be a cornerstone of public health, protecting people from numerous infectious diseases and significantly reducing the burden on healthcare systems. The smallpox vaccine, developed by Edward Jenner in 1796, led to the complete eradication of the disease by 1980, making it the only human disease to be eradicated globally. Aurigene applauds all scientists across the world, today or years ago, for their relentless puruit in improving the lives and health of people across the globe! #Didyouknow #PharmaQuiz #trivia

Aurigene is setting the pace at Biomanufacturing World Summit 2024! Join us in exploring new innovations and trends in biologics. 📅 November 19-21, 2024 📍 Hilton San Diego Bayfront, San Diego, CA 📍 Booth #02 We are excited to participate in the Biomanufacturing World Summit 2024! Visit our booth to discover how we are advancing the field of biologics with cutting-edge research, development and cGMP manufacturing. 🔬 What We Offer: • End-to-end services: From discovery to commercial cGMP manufacturing. • Expertise across modalities: Monoclonal antibodies, Bi-specific antibodies and recombinant proteins. • State-of-the-art facilities: Ensuring the highest safety and quality standards. • Proven quality systems: Supporting clinical development and commercialization. Aurigene’s comprehensive biologics services can accelerate your product's journey from lab to market. Don't miss out! Write to us at contactapsl@aurigeneservices.com to schedule a meeting with our experts attending Biomanufacturing World Summit 2024! #Biomanufacturing #Biologics #Innovation #Aurigene #BMWS2024 Roger Lias Jenny Yip Amit Jogi Akshay Shukla Ruksana Khatoon

🎉 𝐂𝐨𝐧𝐠𝐫𝐚𝐭𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐭𝐨 𝐓𝐮𝐬𝐡𝐚𝐫 𝐙𝐚𝐝𝐞! 🎉   We are thrilled to congratulate our CDO & CIO, Tushar Zade, on receiving the prestigious 'Digital Infrastructure Mastermind' and 'Progressive CIO' awards for the third consecutive year!   These remarkable achievements are a testament to Tushar's visionary leadership and the relentless dedication of his incredible team. 🌟   Tushar's words perfectly capture the spirit of this accomplishment: "𝘛𝘩𝘦𝘴𝘦 𝘢𝘸𝘢𝘳𝘥𝘴 𝘣𝘦𝘭𝘰𝘯𝘨 𝘵𝘰 𝘮𝘺 𝘢𝘮𝘢𝘻𝘪𝘯𝘨 𝘵𝘦𝘢𝘮. 𝘛𝘩𝘦𝘪𝘳 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯, 𝘤𝘰𝘮𝘮𝘪𝘵𝘮𝘦𝘯𝘵, 𝘢𝘯𝘥 𝘱𝘢𝘴𝘴𝘪𝘰𝘯 𝘮𝘢𝘬𝘦 𝘪𝘵 𝘱𝘰𝘴𝘴𝘪𝘣𝘭𝘦 𝘧𝘰𝘳 𝘶𝘴 𝘵𝘰 𝘢𝘤𝘩𝘪𝘦𝘷𝘦 𝘨𝘳𝘦𝘢𝘵 𝘵𝘩𝘪𝘯𝘨𝘴. 𝘛𝘩𝘢𝘯𝘬 𝘺𝘰𝘶 𝘵𝘰 𝘵𝘩𝘦 𝘧𝘢𝘮𝘪𝘭𝘪𝘦𝘴 𝘸𝘩𝘰 𝘴𝘶𝘱𝘱𝘰𝘳𝘵 𝘮𝘺 𝘵𝘦𝘢𝘮 𝘮𝘦𝘮𝘣𝘦𝘳𝘴; 𝘺𝘰𝘶𝘳 𝘦𝘯𝘤𝘰𝘶𝘳𝘢𝘨𝘦𝘮𝘦𝘯𝘵 𝘨𝘪𝘷𝘦𝘴 𝘵𝘩𝘦𝘮 𝘵𝘩𝘦 𝘴𝘵𝘳𝘦𝘯𝘨𝘵𝘩 𝘵𝘰 𝘦𝘹𝘤𝘦𝘭."   Together, we are pushing boundaries, achieving milestones, and shaping the future of Aurigene Pharmaceutical Services. This success is a shared journey, and we are excited to continue reaching for the stars! 🌠   A special thanks to Akhil Ravi for his mentorship and to Yogesh Gupta and IDC Foundry Events India for this honor.   Let's keep driving forward and creating more value together! 🙌   #Aurigene #Leadership #Innovation #TeamSuccess #Awards

🌟 Happy Dussehra from Aurigene! 🌟   As we celebrate the triumph of good over evil, Aurigene extends heartfelt wishes for a joyous and prosperous Dussehra to all our colleagues, clients, and partners.   May this festive season bring happiness, health, and success to you and your loved ones. Let's continue to strive for excellence and innovation in our journey together.   #HappyDussehra #Aurigene #FestiveGreetings

🌟 We are live at CPHI Milan! 🌟 We’re delighted to be at CPHI Milan, one of the world’s largest pharmaceutical conventions! Come visit us at booth #7B82 from October 8th to 10th and discover how Aurigene’s dedicated team and state-of-the-art infrastructure can support your innovation journey. ✨ Here’s what we offer:   🔺 cGMP US FDA inspected API, Intermediates, and Formulation sites   🔺 US FDA inspected GLP labs   🔺 Flexibility of scale: grams to multi-tons   🔺 Expertise in flow peptides, steroids, and mPEGs   🔺 Advanced capabilities: flow chemistry, biocatalysis, and high potent APIs 📅 Let’s connect! Schedule a meeting by emailing us at contactapsl@aurigeneservices.com. We look forward to meeting you in Milan and exploring how we can work together to achieve your goals! #AurigeneConnect #CPHIMilan #PharmaceuticalInnovation #GMPManufacturing   Akhil Ravi Kapil Choudhury Srividya Ramakrishnan Roger Lias Raj Sharma (Ph.D) ASHWINI KUMAR KAPOOR